FIND AN EXPERT

Select information from any of the fields below and click search.

 
Publications 2008

Storm clouds hang over Swiss-type claims

A year on from the implementation of EPC 2000, those seeking to lodge claims to protect further medical use should be aware of the dangers of continuing former practice. Article paru dans le numéro de Novembre-Décembre 2008 du magazine "World Intellectual Property Review". Rédacteurs : Lionel Vial, Sonia Dias and...
Read more

Patent exemption for clinical trials : current status of the Bolar-type provisions in Europe

Analyse of the patent exemption provided by Directive EC 2004/27 and summary of the current status of its implementation in each of the member states. Article published in "Life Sciences Intellectual Property Review 2008". Writers : Stéphanie Michiels and Béatrice Holtz. To read this article, click on the link below
Read more

A brief history of Swiss-type claims

Changes to European patent law have brought an end to the need for Swiss-type claims. What does replace them? Article published in June 2008 in the n°180 of Managing Intellectual Property "Patent pioneers. Inventions that built the Biotech Industry". Writers: Béatrice Holtz and Lionel Vial. To read this article, click on the...
Read more

A difficult birth: gene patenting is experiencing problems in French legislation

French law has recently brought in the Legal Protection of Biotechnological Inventions European Directive. Its implementation has caused surprising uncertainty about patent protection of isolated gene sequences in France. Article published in February 2008 in the n°176 of Managing Intellectual Property "The leading patent firms...
Read more

The BOLAR Exemption In European Union (EU)

Until recently, pre-patent expiry testing work was not harmonized by European law. This created significant differences as to whether clinical trial work conducted for generic drug approval was considered patent infringement according to the individual national laws of the EU Member States. In order to harmonize clinical trial...
Read more
1 2


Archives